Kalkine has a fully transformed New Avatar.

Last update at 2026-03-10T16:35:00Z
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
Croda International First Half 2025 Earnings: EPS: UK£0.44 (vs UK£0.57 in 1H 2024)
Fri 01 Aug 25, 02:27 PMCroda International Plc (LON:CRDA) Just Reported Earnings, And Analysts Cut Their Target Price
Thu 31 Jul 25, 12:22 PMCroda International Plc (LON:CRDA) Shares Could Be 35% Below Their Intrinsic Value Estimate
Wed 30 Jul 25, 05:33 AMFTSE 100 climbs as earnings cascade brings cheer
Tue 29 Jul 25, 04:36 PMCroda International (COIHY) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
Thu 17 Jul 25, 01:55 PMCroda International Full Year 2024 Earnings: EPS Misses Expectations
Sat 15 Mar 25, 08:21 AMIs Croda International Plc's (LON:CRDA) Stock On A Downtrend As A Result Of Its Poor Financials?
Sun 09 Mar 25, 08:25 AMCroda International And 2 Other UK Dividend Stocks To Consider
Thu 20 Feb 25, 08:02 AM| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Income before tax | 91.00M | 207.80M | 236.30M | 780.00M | 411.50M |
| Minority interest | - | -1.10000M | -1.10000M | -4.00000M | -2.00000M |
| Net income | 62.00M | 158.50M | 171.00M | 649.30M | 320.80M |
| Selling general administrative | - | 427.20M | 405.30M | 439.10M | 407.70M |
| Selling and marketing expenses | - | 79.20M | 77.20M | 101.80M | 93.00M |
| Gross profit | 608.70M | 733.90M | 730.00M | 985.60M | 938.90M |
| Reconciled depreciation | - | 135.80M | 126.20M | 120.70M | 113.30M |
| Ebit | 243.70M | 238.70M | 262.30M | 444.70M | 438.20M |
| Ebitda | 380.70M | 374.50M | 388.50M | 554.50M | 546.60M |
| Depreciation and amortization | 137.00M | 135.80M | 126.20M | 109.80M | 108.40M |
| Non operating income net other | - | - | - | - | - |
| Operating income | 243.70M | 227.50M | 247.50M | 444.70M | 438.20M |
| Other operating expenses | 1455.70M | 1400.60M | 1447.00M | 1608.50M | 1457.80M |
| Interest expense | 28.30M | 30.90M | 25.90M | 8.30M | 25.70M |
| Tax provision | - | 48.20M | 64.20M | 126.70M | 88.70M |
| Interest income | - | 11.30M | 14.80M | 5.10M | 1.50M |
| Net interest income | - | -19.70000M | -11.20000M | -20.70000M | -24.20000M |
| Extraordinary items | - | - | - | - | - |
| Non recurring | - | - | - | - | - |
| Other items | - | - | - | - | - |
| Income tax expense | 26.30M | 48.20M | 64.20M | 126.70M | 88.70M |
| Total revenue | 1699.40M | 1628.10M | 1694.50M | 2089.30M | 1889.60M |
| Total operating expenses | 365.00M | 506.40M | 482.50M | 504.80M | 507.10M |
| Cost of revenue | 1090.70M | 894.20M | 964.50M | 1103.70M | 950.70M |
| Total other income expense net | -152.70000M | -19.70000M | -11.20000M | 335.30M | -26.70000M |
| Discontinued operations | - | - | - | - | - |
| Net income from continuing ops | - | 159.60M | 172.10M | 653.30M | 322.80M |
| Net income applicable to common shares | - | - | - | 649.30M | 320.80M |
| Preferred stock and other adjustments | - | - | - | - | - |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2023-06-30 | 2022-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2023-06-30 | 2022-12-31 |
| Total assets | 3411.00M | 3509.30M | 3579.20M | - | 3611.90M |
| Intangible assets | - | 411.00M | 470.60M | - | 408.60M |
| Earning assets | - | - | - | - | - |
| Other current assets | - | 51.30M | 77.70M | - | 375.80M |
| Total liab | 1208.90M | 1212.40M | 1211.10M | - | 1180.80M |
| Total stockholder equity | 2187.10M | 2282.50M | 2352.50M | - | 2415.60M |
| Deferred long term liab | - | - | - | - | - |
| Other current liab | 13.50M | 140.80M | 134.80M | - | 33.00M |
| Common stock | 15.10M | 15.10M | 15.10M | - | 15.10M |
| Capital stock | - | 15.10M | 15.10M | - | 15.10M |
| Retained earnings | 1567.00M | 1660.10M | 1640.00M | - | 1645.70M |
| Other liab | - | - | - | - | 212.00M |
| Good will | - | 899.60M | 937.90M | - | 844.60M |
| Other assets | - | - | 0.00000M | - | 133.50M |
| Cash | 172.80M | 166.80M | 172.50M | - | 320.60M |
| Cash and equivalents | - | - | - | - | - |
| Total current liabilities | 456.60M | 336.50M | 320.20M | - | 487.80M |
| Current deferred revenue | - | - | 9.20M | - | - |
| Net debt | 587.50M | 532.30M | 537.60M | - | 295.20M |
| Short term debt | 162.60M | 48.20M | 50.40M | - | 134.80M |
| Short long term debt | - | 35.00M | 36.70M | - | 121.90M |
| Short long term debt total | 760.30M | 699.10M | 710.10M | - | 615.80M |
| Other stockholder equity | 707.70M | 707.70M | 707.70M | - | 754.80M |
| Property plant equipment | - | - | - | - | 1061.40M |
| Total current assets | 907.10M | 884.20M | 909.40M | - | 1160.40M |
| Long term investments | - | - | - | - | - |
| Net tangible assets | - | - | - | - | 1162.40M |
| Short term investments | - | - | - | - | - |
| Net receivables | 363.80M | 298.20M | 318.00M | - | 375.80M |
| Long term debt | - | 580.20M | 588.40M | - | 401.80M |
| Inventory | 370.50M | 367.90M | 341.20M | - | 464.00M |
| Accounts payable | 280.50M | 126.70M | 125.80M | - | 320.00M |
| Total permanent equity | - | - | - | - | - |
| Noncontrolling interest in consolidated entity | - | - | - | - | - |
| Temporary equity redeemable noncontrolling interests | - | - | - | - | - |
| Accumulated other comprehensive income | -102.70000M | -100.40000M | -10.30000M | - | - |
| Additional paid in capital | - | - | - | - | - |
| Common stock total equity | - | - | - | - | - |
| Preferred stock total equity | - | - | - | - | - |
| Retained earnings total equity | - | - | - | - | - |
| Treasury stock | - | - | - | - | - |
| Accumulated amortization | - | - | - | - | - |
| Non currrent assets other | 137.70M | 130.00M | 113.50M | - | 126.60M |
| Deferred long term asset charges | - | - | - | - | - |
| Non current assets total | 2503.90M | 2625.10M | 2669.80M | - | 2451.50M |
| Capital lease obligations | - | 83.90M | 85.00M | - | 92.10M |
| Long term debt total | - | - | - | - | - |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Investments | - | -139.10000M | -409.80000M | 424.60M | -216.20000M |
| Change to liabilities | - | - | - | 7.60M | 91.60M |
| Total cashflows from investing activities | -109.80000M | -139.10000M | -409.80000M | 424.60M | -216.20000M |
| Net borrowings | - | -9.00000M | 125.10M | -399.20000M | 23.20M |
| Total cash from financing activities | -152.60000M | -182.60000M | -52.40000M | -552.30000M | -112.60000M |
| Change to operating activities | - | - | - | - | - |
| Net income | 62.00M | 279.70M | 171.00M | 515.10M | 438.20M |
| Change in cash | 6.00M | -8.50000M | -131.40000M | 187.30M | 16.50M |
| Begin period cash flow | 166.80M | 150.20M | 281.60M | 94.30M | 77.80M |
| End period cash flow | 172.80M | 141.70M | 150.20M | 281.60M | 94.30M |
| Total cash from operating activities | 289.50M | 319.40M | 337.50M | 308.20M | 347.70M |
| Issuance of capital stock | - | - | - | - | 0.00000M |
| Depreciation | 137.00M | 135.80M | 126.20M | 120.70M | 113.30M |
| Other cashflows from investing activities | 9.80M | 39.30M | -5.20000M | -8.30000M | 0.40M |
| Dividends paid | 154.90M | 152.20M | 150.70M | 144.40M | 132.50M |
| Change to inventory | -7.30000M | -39.30000M | 117.80M | -98.10000M | -140.90000M |
| Change to account receivables | -16.60000M | 21.30M | -19.00000M | -43.30000M | -53.20000M |
| Sale purchase of stock | -7.30000M | -1.80000M | -9.80000M | - | -2.40000M |
| Other cashflows from financing activities | -19.70000M | -19.60000M | -17.00000M | 206.50M | -0.70000M |
| Change to netincome | - | - | - | -293.70000M | 50.40M |
| Capital expenditures | 117.70M | 181.80M | 189.00M | 152.40M | 158.70M |
| Change receivables | - | - | - | - | - |
| Cash flows other operating | - | - | - | - | - |
| Exchange rate changes | - | - | - | - | - |
| Cash and cash equivalents changes | - | - | - | - | - |
| Change in working capital | -7.70000M | 20.90M | 29.10M | -133.80000M | -102.50000M |
| Stock based compensation | - | 5.00M | -4.20000M | -11.00000M | 29.10M |
| Other non cash items | 98.20M | -122.00000M | 15.40M | -182.80000M | -6.20000M |
| Free cash flow | 171.80M | 137.60M | 156.80M | 155.80M | 189.00M |
Sector: Basic Materials Industry: Specialty Chemicals
| Company | Change (GBX) | Price (GBX) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | Enterprise Value to Revenue (x) | Enterprise Value to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| CRDA Croda International PLC |
- -% | 2780.00 | 64.70 | 16.61 | 2.34 | 1.83 | 2.67 | 17.69 |
| JMAT Johnson Matthey PLC |
- -% | 1943.00 | 17.60 | 9.99 | 0.22 | 1.29 | 0.29 | 7.58 |
| VCT Victrex plc |
- -% | 629.00 | 22.11 | 17.24 | 4.28 | 2.62 | 4.43 | 14.00 |
| ELM Elementis PLC |
- -% | 152.80 | - | 15.58 | 1.04 | 1.12 | 1.36 | 23.41 |
| 87FZ AECI Ltd |
- -% | 0.66 | 0.01 | - | 0.02 | - |
Croda International Plc engages in the consumer care, life science, and industrial specialty businesses in Europe, the Middle East, Africa, North America, Asia, and Latin America. The company offers consumer care products across beauty care, beauty actives, and home care products, as well as fragrances and flavours. It also provides biologics drug delivery, crop protection, and seed coating systems and enhancement technologies to improve germination. In addition, the company offers industrial specialties, including phase change materials; surfactants, such as emulsifiers, dispersants, wetting agents, detergents, and polymerics; and formulated textile and spin finishes. Croda International Plc was incorporated in 1925 and is headquartered in Goole, the United Kingdom.
Cowick Hall, Goole, United Kingdom, DN14 9AA
| Name | Title | Year Born |
|---|---|---|
| Mr. Stephen Edward Foots | Group Chief Exec. & Exec. Director | 1969 |
| Mr. Jeremy K. Maiden BA, FCMA | Group Fin. Director & Exec. Director | 1962 |
| Mr. Mark Robinson | Pres of Global Operations | NA |
| Mr. Nicholas Ian Challoner | Group Chief Scientific Officer | NA |
| Mr. David Bishop | Director of Investor Relations | NA |
| Mr. Thomas Michael Brophy | Group Gen. Counsel & Company Sec. | 1974 |
| Mr. Anthony Damien Fitzpatrick | Pres of Performance Technologies, Industrial Chemicals & Corp. Devel. | NA |
| Ms. Tracy Sheedy | Group Human Resource Director | NA |
| Ms. Sandra Elaine Breene | Pres of Regional Delivery | NA |
| Mr. David Cherry | Managing Director of Crop Protection | NA |
Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.